Single Dose of Intravenous Ferric Carboxymaltose Prevents Anemia for 6 Months among Moderately or Severely Anemic Postpartum Women: A Case Study from India

The effectiveness of intravenous ferric carboxymaltose (FCM) in quickly increasing normal hemoglobin concentration and replenishing body iron reserves up to 6–12 wk is known; however, its long-term effectiveness is unknown. In this study conducted in northern India during August 2018 to February 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Ravneet, Kant, Shashi, Haldar, Partha, Ahamed, Farhad, Singh, Archana, Dwarakanathan, Vignesh, Malhotra, Sumit, Yadav, Kapil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
BRIEF COMMUNICATION: CASE STUDY REPORT
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275451/
https://www.ncbi.nlm.nih.gov/pubmed/34268465
http://dx.doi.org/10.1093/cdn/nzab078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275451/
https://www.ncbi.nlm.nih.gov/pubmed/34268465
http://dx.doi.org/10.1093/cdn/nzab078

Ejemplares similares